1. Tremfya is a biologic drug used to treat psoriasis.
2. Endari is intended to treat serious complications associated with sickle cell disease and represents the first approved treatment for the condition in nearly two decades.
3. Blincyto is used to treat pediatric and adult patients with a specific type of acute lymphoblastic leukemia.
More articles on supply chain:
7 must-reads for supply chain leaders this week
House passes FDA user fee reauthorization bill
Are outcomes-based drug contracts effective? 5 thoughts
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.